OncoSil Medical Limited (ASX: OSL)
Health Care · Life Sciences Tools & Services · AU
AU$0.70
-11.39% today · -59.5% 1Y
OncoSil Medical Limited (ASX: OSL) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $17.93M and employs 6 people.
Over the last twelve months the share price has lost 59.5%, trading between 0.37 and 1.81.
Tweenvest scores OncoSil Medical Limited across four factors: quality 38/100, value 69/100, growth 100/100. Its strongest factor is growth.
OSL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.93M
- Revenue (TTM)
- $3.52M
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 1.31
- 52-week high
- AU$1.81
- 52-week low
- AU$0.37
- Avg volume (3M)
- —
- Shares outstanding
- 36.70M
- Employees
- 6
- Next earnings
- —
About OncoSil Medical Limited
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
- ISIN
- AU000000OSL3
- Founded
- 2005
- Listed since
- Aug 12, 2005
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| C&R Research Inc.KOSDAQ: A359090 | $19.88M | ₩2,325.00 | +1.97% |
| SLS BIO Co., LtdKOSDAQ: A246250 | $19.85M | ₩— | — |
| Genolution Inc.KOSDAQ: A225220 | $19.41M | ₩1,444.00 | -1.70% |
| Promimic AB (publ)OM: PRO | $18.42M | Skr9.60 | -1.54% |
| Oxford BioDynamics PlcAIM: OBD | $17.79M | £0.00 | -13.04% |
| Veritas In Silico Inc.TSE: 130A | $17.45M | ¥426.00 | -1.84% |
| Jeevan Scientific Technology LimitedBSE: 538837 | $17.35M | Rs83.60 | -1.31% |
| Bionano Genomics, Inc.NasdaqCM: BNGO | $16.90M | $1.31 | -8.71% |
Figures last refreshed Oct 11, 2026.